PTCT
PTC Therapeutics Inc
Price:  
46.45 
USD
Volume:  
545,790.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT WACC - Weighted Average Cost of Capital

The WACC of PTC Therapeutics Inc (PTCT) is 8.1%.

The Cost of Equity of PTC Therapeutics Inc (PTCT) is 9.90%.
The Cost of Debt of PTC Therapeutics Inc (PTCT) is 5.50%.

Range Selected
Cost of equity 7.70% - 12.10% 9.90%
Tax rate 4.90% - 6.40% 5.65%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.2% - 10.0% 8.1%
WACC

PTCT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.84 1.29
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 12.10%
Tax rate 4.90% 6.40%
Debt/Equity ratio 0.63 0.63
Cost of debt 4.00% 7.00%
After-tax WACC 6.2% 10.0%
Selected WACC 8.1%